c-Rel+ DLBCL with MUT-p53 which was associated with significantly worse survival (Fig. 2H-2I), also correlated with decreased pAKT and Myc expression (Supplementary Fig. S2I-2J), as seen in c-Rel+ DLBCL with WT-p53 which did not show worse survival by univariate survival analysis (Fig. 2G). The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.